Quintiles Makes Second Investment in Prana
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Prana`s PBT2 Directly Restores Neurons Critical to Cognition
- Prana Receives Michael J. Fox Foundation Grant
- Prana Announces At-the-Market Issuance Program
- PBT2 reverses the loss of synaptic activity in neurons
- Landmark Publication Endorses Prana`s Strategy
Later from Alterity Therapeutics
- Appendix 4E for the Year Ended 30 June 2010
- Investment by Quintiles, Placement of 225 million Shares
- Prana Provides Analysis of PBT2 Therapeutic Strategy for AD
- Prana selects lead PD drug candidate for development
- Prana to commence Phase 11b trial on PBT2
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics